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Abstract.  Vincristine-resistant (VCR) Chinese hamster 
ovary (CHO) cells have been established by stepwise 
selection in increasing concentrations of vincristine. 
These cells exhibit multidrug cross-resistance to a 
number of drugs that have no structural or functional 
similarities. Cytogenetic analyses of resistant cells re- 
vealed the presence of double minutes and expanded 
chromosomal segments, thus implicating gene am- 
plification as a possible mechanism of resistance. An 
amplified DNA segment isolated from other multidrug 
cross-resistant CHO cell lines (Roninson, I.  B.,  H.  T. 
Abelson, D. E. Housman, N.  Howell, and A. Var- 
shavsky,  1984,  Nature (Lond.), 309:626-628)  is also 
amplified in our VCR lines. This DNA segment was 
used as a probe to screen a  cosmid library of VCR 
genomic DNA, and overlapping clones were retrieved. 
All of these segments, totaling ,x,45 kilobases (kb), 
were amplified in VCR cells. Using in situ hybridiza- 
tion, we localized the amplification domain to the long 
arm of CHO chromosome 1 or Z1.  Northern hybrid- 
ization analysis revealed that a  4.3-kb mRNA was en- 
coded by this amplified DNA domain and was over- 
produced in the VCR cells. Suggestions for the 
involvement of these amplified DNA segments in the 
acquisition of multidrug cross-resistance in animal 
cells are also presented. 
major obstacle to effective cancer chemotherapy is the 
development of drug resistance. The establishment 
of cells in culture resistant to the cytotoxicity of the 
tested drug remains a valuable approach in the study of mech- 
anisms of clinical drug resistance. Multidrug drug resistance 
(MDR), l a phenomenon of cross-resistance to a variety of 
different drugs that have no similarities in their modes of ac- 
tion, has been observed in cultured animal cells primarily 
selected for resistance to various plant alkaloids or anthracy- 
clines. A number of studies have been done to determine the 
mechanisms of MDR, and some of these have suggested that 
alterations in cytoplasmic membrane structure decrease in- 
tracellular accumulation of functionally diverse cytotoxic 
agents. Several investigators have reported such alterations 
in terms of overproduction of various cell surface glycopro- 
teins (1, 2, 5, 13, 18) and accelerated drug efllux (11, 31) from 
resistant  cells.  Other  reports  describe  overproduction of 
cytosolic proteins (19-21) or decreased amounts of cell sur- 
face glycoproteins (22) in various MDR cell lines. In many 
cases, resistance can be circumvented by adding calmodulin 
inhibitors or calcium channel blockers to the culture medium 
(32). 
1. Abbreviations used in thispaper: CHO, Chinese hamster ovary cells; Ix 
Denhardt's, 0.02%  each of ficoll, polyvinylpyrollidone, and BSA;  DM, 
double-minute chromosomes; EDs0, effective dose for 50% killing; MDR, 
multidrug resistance; Ix SSC: 0.15 M NaCI, 0.015 M Na citrate; Ix SSPE: 
0.18 M  NaCI,  10 mM NaPO4  (pH 7.7),  1 raM EDTA; VCR,  vincristine 
resistant. 
Additional reports demonstrated that abnormal structures 
such as double-minute chromosomes (DM) and homogenous 
staining region-like segments are present in MDR cell lines, 
suggesting that gene amplification may be involved (14, 15, 
21).  Recently,  two  reports  have  been  published  showing 
DNA amplification in Chinese hamster ovary (CHO) cells. 
Roninson et al.  (24)  used an elegant in-gel denaturation/ 
renaturation method to show that DNA amplification had 
occurred in two MDR CHO cell lines. Fojo et al. (7) have 
recently applied the same technique in analysis of their hu- 
man MDR cells lines, yielding similar results. Another re- 
port by Riordan et al. (23) demonstrated that the gene encod- 
ing a 175-kD membrane glycoprotein is amplified in an MDR 
CHO cell line that was established by selection in colchicine. 
In the present report, we show that gene amplification has 
also occurred in our independently established vincristine- 
resistant (VCR) CHO cells exhibiting MDR. Unique features 
in terms of cytogenetic manifestations and expression of the 
amplified gene in these MDR cell lines are also presented. 
Materials and Methods 
Cell Culture, Establishment of  Drug- 
resistant Cell Lines, and Cytotoxicity Test 
of the Mutants 
All cell lines were maintained as monolayer cultures at 37°C in 5% CO2 
in air in Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY) 
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0.1% neomycin (Pharma-Tek, Inc., Huntington, NY). Procedures for selec- 
tion of VCR 1.5 and VCR 5 (designating survival in 1.5 ~tg/ml and 5 I~g/ml 
vincristine, respectively)  have been described (15). VCR 5 was originally 
referred to as VCR 6-7 (15). VCR 15 cells were established from VCR 5 by 
further selection in progressive increased vincristine concentrations, ac- 
cording to the following schedule:  10 lig/ml~12.5 p,g/ml---15 lxg/ml--~17.5 
~tg/ml. Cells surviving at 17.5 lag/ml were routinely grown in 15 ~tg/ml of 
vincristine. 
Dosage-response  analysis  was performed on cell lines by plating 500 
cells in 3.5-cm  dishes (Coming Glass Works, Coming Science  Products, 
Coming, NY) in regular medium containing various concentrations of vin- 
cristine (Sigma Chemical Co., St. Louis, MO), Colcemid (Gibeo), puromy- 
tin  (Calbiochem-Behring Corp.,  La  Jolla,  CA),  or  ethidium bromide 
(Sigma Chemical Co.).  After colonies developed  (,,o10 d), the plates were 
stained with 5%  crystal  violet made in 5%  ethanol and colonies were 
counted. 
Cytogenetic  Analysis 
Cells were blocked in mitosis by adding Colcemid (0.06 p.g/mi for CHO, 
10 Ixg/mi for VCR 1.5 cells,  and 20 ~tg/ml for VCR 5 and VCR 15 cells). 
Mitotic cells were harvested by gentle shake-off, swollen in 75 mM KCI for 
15 rain at room temperature,  and fixed in three sequential changes of fixative 
(3:1 vol/vol,  methanol/acetic acid). Air-dried slides were either stained by 
Giemsa  (Gurr,  Poole,  England)  (5%  in  10  mM  NaPO4  [pH  6.8])  or 
ethidium bromide (50 ~g/ml for 20 rain at 25"C) and scored for DM chro- 
mosomes.  Giemsa-trypsin (G-band) procedure was performed by the estab- 
lished method. CHO chromosomes were identified  by the characteristic 
G-banding pattern described by Deaven and Petersen  (6). 
Preparation  and Screening  of  Cosmid  Library 
High molecular weight DNA isolated from VCR  15 cells was  partially 
digested by MboI (New England Biolabs,  Beverly, MA) and the restriction 
fragments were fractionated by sucrose gradient centrifugation.  DNA frag- 
ments of 30-45 kilobases (kb) were used to construct a cosmid library in 
pCV108. Detailed  procedures were described by Ish-Horowicz  and Burke 
(12) and modified  by Lau and Kan  (16). The cosmid DNA library was 
screened by the method described by Hanahan and Meselson (10) using the 
insert ofpDRl.1 as a probe (24) (a gift from Dr. Igor Roninson,  University 
of Illinois College  of Medicine at Chicago). 
Other Procedures 
Procedures  for isolation  of DNA and RNA, and for in situ hybridization 
were  those described previously (27).  For  Southern blot hybridization, 
DNA was digested with restriction enzyme to completion. After digestion, 
DNA was  extracted  with phenol/chloroform/isoamylalcohol  and ethanol 
precipitated.  An equal amount of DNA  (10 ~tg) was loaded onto a  1% 
agarose  gel, electrophoresed,  and blotted onto nitrocellulose  membrane. 
Hybridizations were carried out in 50%  formamide,  5×  SSPE,  1 Den- 
hardts, and 1(30 lig/ml  denatured salmon sperm DNA at 42°C.  Northern 
hybridizations were  in 50%  formamide,  10% dextran sulfate,  1×  Den- 
hardt's, 0.05 M Tris-HC1 (pH 7.5), 1 M NaC1, 0.1% sodium pyrophosphate, 
1% SDS, and 100 eg/ml salmon sperm DNA at 42°C.  In each case,  •1  × 
107 cpm denatured, nick-translated  probe were added. Both hybridizations 
were washed under the following conditions:  twice for 15 min in 2x SSC 
and 0.1% SDS at room temperature;  twice for 30 rain in 2x SSC and 1% 
SDS at 65-700C; and twice for 30 min in 0.1×  SSC and 0.1% SDS at room 
temperature. 
Results 
Table I shows  the effective doses for 50%  killing (ED50) of 
wild-type CHO cells and for VCR CHO mutants grown in 
the presence of different concentrations of vincristine, col- 
cemid, ethidium bromide, and puromycin. The EDs0 to vin- 
cristine for CHO, VCR 1.5, VCR 5, and VCR 15 are 0.05, 2, 
10, and 25 gg/ml, respectively. Therefore, mutants VCR 1.5, 
VCR 5, and VCR 15 were 40-, 200-, and 500-fold more resis- 
tant respectively, to the toxicity of vincristine than the wild 
type. These mutants were also cross-resistant to the cyto- 
toxicities of the other three drugs tested. These drugs share 
no common structural or functional similarities with vin- 
cristine. The EDso for CHO and VCR mutants shown in Ta- 
ble I demonstrated that the VCR mutant cell lines are MDR 
mutants. We noted that the levels of cross-resistance in these 
MDR mutants progressively increase as the steps of  selection 
increase. It is also apparent that in VCR mutants, the level 
of cross-resistance to other drugs is always lower than resis- 
tance to vincristine. 
Chromosomal Abnormalities in Vincristine- 
resistant Mutants 
We investigated  whether there are any chromosomal abnor- 
malities in these VCR mutants.  Chromosome spreads  were 
prepared from wild-type CHO cells and from VCR mutants, 
stained  by Giemsa, and observed under a light microscope. 
Abnormal chromosomal structures including dicentric chro- 
mosomes,  ring  chromosomes,  endoreduplicated  chromo- 
somes,  and chromosomes  with breaks  and gaps  were fre- 
quently  observed  in  ,~5%  of VCR  1.5  cells  (not  shown). 
Figure 1.  Giemsa-stained metaphase spreads 
of VCR 1.5 cells. Arrows, the double minutes. 
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served in the wild-type CHO lines (<0.1%). 
The  most  often  observed  abnormality  in  metaphase 
spreads of VCR 1.5 cells were DM (Fig.  1). About 50% of 
VCR  1.5 cells contained DM; the number of DM per cell 
ranged from 0 to "~,50. Usually higher number of DM were 
found in polyploid cells (Fig.  1) than in near diploid cells. 
DM were not found in wild-type CHO cells. 
The described abnormal chromosomal structures were not 
frequently found (<2 % of the cells) in cell lines with high 
levels of VCR, i.e., VCR 5 and VCR  15 ceils. Instead, the 
most significant chromosomal abnormality associated with 
VCR 5 and VCR 15 cells was the presence of an additional 
chromosomal segment. Fig. 2 shows a composite karyotype 
of the CHO parental line, and MDR mutant lines, VCR 5, 
and VCR  15, analyzed after Giemsa-trypsin banding.  Over 
20 complete karyotypes were analyzed and each chromo- 
some Z7 in the mutant cells possessed an addition to the telo- 
mere of  the long arm. The additional chromosomal segments 
on Z7 in these VCR mutants showed discernible banding pat- 
terns rather than a homogenous staining pattern that are pres- 
ent in a number of drug-resistant cell lines (4). In addition, 
there appears a constricted region on the long arm of Z1, ex- 
hibiting an abnormally banding region. Abnormally banding 
regions containing a  low level of gene amplification have 
been reported in other drug-resistant cells (17). 
Gene Amplification and Overexpression 
of mRNA in VCR Cells 
The presence of DM and an additional chromosomal seg- 
ment in the VCR mutants suggests that gene amplification 
may have occurred in these mutants.  We therefore used a 
cloned DNA sequence (pDRI.1) that was amplified in two 
MDR CHO cell lines independently selected for resistance 
to adriamycin and colchicine to determine whether the same 
DNA sequence is also amplified in our VCR cell lines. 
Southern hybridization of the pDRI.1  probe to genomic 
DNAs from CHO and VCR cells demonstrated amplification 
of this DNA segment in resistant cells (data not shown). Be- 
cause the sequence that hybridized with the insert of pDRI.1 
was  not transcribed in the VCR mutants  (not shown),  we 
screened a 500,000-clone cosmid library prepared from VCR 
15 DNA with the insert of pDRI.I  to search for flanking, 
transcribed sequences. Two cosmid DNA clones, designated 
pDR6 and pDR7, were isolated. Fig. 3 shows the restriction 
enzyme cleavage sites of BglI, EcoRI, PstI, and Barn HI on 
pDR6 and pDRT, with the location of pDRI.1 indicated. The 
restriction enzyme map for BamHI generally agrees with 
that recently published by Gros et al. (8). 
We used pDR6 as a probe to determine whether the se- 
quences other than that in the pDRI.1 were also amplified in 
these VCR cell lines. Fig. 4 a  shows an autoradiogram of a 
Southern  blot  hybridization  of  EcoRI-digested  genomic 
DNAs from CHO, VCR  1.5, VCR 5, and VCR  15 cells hy- 
bridized with 32P-labded pDR6 DNA. The same amount of 
DNA  (I0 ~tg) was loaded on each lane and autoradiogram 
was exposed for the same length of time (24 h). Hybridiza- 
tion signals corresponding to EcoRI restriction fragments of 
8, 6, 4, 2.8, and 2 kb were shown in the VCR samples but 
not visible in the CHO sample. This indicated that all the se- 
quences in these fragments were amplified in these VCR cell 
lines. We noted that no significant further amplification of 
these DNA sequences occurred during the selection of VCR 
15 cells from VCR 1.5 (judged from the band intensities of 
the VCR 15 sample and VCR 1.5 sample as shown in the auto- 
radiogram;  Fig. 4  a,  lanes 2-4).  Consistent hybridization 
signals were seen for the VCR 1.5, VCR 5, and VCR 15 sam- 
pies and no new hybridization bands were seen in the DNA 
samples from more resistant cell lines. Furthermore, all the 
EcoRI fragments as detected by Southern blot hybridization 
shown in Fig. 4 a  can be located from the restriction map 
for the pDR6, as Fig. 3 shows. These results suggest that no 
major DNA rearrangement occurred in this amplified DNA 
locus. Using the entire pDR6 as a hybridization probe, we 
have consistently failed to detect a clear hybridization signal 
from the CHO sample. The reason for this is probably the 
presence of repetitive DNA sequences in the pDR6 insert. 
In fact, such repetitive sequences may also have caused the 
high hybridization background Fig. 4 a  shows. 
To address this problem, we sought to determine the loca- 
tions of repeated DNA sequences in the cosmids, pDR6, and 
Figure 2. Giemsa-trypsin banding of CHO parental line and VCR mutants. Chromosomal arrangement is according to that published by 
Deaven and Peterson (6). In each case, the CHO chromosomes are shown on the left, VCR 5 in the middle, and VCR 15 on the right. 
Arrow, the additional chromosome segment. 
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Figure 3. Restriction enzyme cleavage sites of the cosmid clones, 
pDR6 and pDR7, plasmid clone pDRI.I.,  and plasmid subclones, 
pDR2-2 and pDR2-4. Only the inserts in these clones are shown. 
The wavy lines  indicate restriction  fragments shown to contain 
repetitive sequences. The numbers represent the sizes (in kilobases) 
of EcoRI fragments detected using pDR6 insert DNA as a probe 
to Southern blot hybridization with genomic VCR DNA digested 
with EcoRI (Fig. 4 a). 
pDR7. pDR6 and pDR7 DNAs were digested with EcoRI, the 
restricted fragments were separated by gel electrophoresis, 
transferred to  a  nitrocellulose filter,  and  hybridized with 
32p-labeled total CHO DNA.  This hybridization favors the 
annealing of repeated DNA sequences. Therefore, the results 
of this experiment allowed us to localize several restriction 
fragments that contain repetitive DNA sequences as Fig. 3 
shows  (wavy  lines).  The  repeat-free EcoRI  fragments  in 
pDR6 were subcloned into pBR322, designated pDR2-2 and 
pDR2-4.  Fig. 3 shows the locations for the inserts of these 
two subclones. 
We used the insert of pDR2-4 as probe to hybridize in a 
Southern blot with 10 Ixg of CHO, VCR 1.5, VCR 5, and VCR 
15 genomic DNAs digested by EcoRI.  Fig. 4  b  shows the 
results of this hybridization. In this  case,  duplicate filters 
were made; one was used to hybridize with the pDR2-4 (Fig. 
4 b) probe and the other to the CHO 13-tubulin cDNA (Fig. 
4 c). The CHO fl-tubulin cDNA, a gift of E  Cabrel (Univer- 
sity of Texas Medical School at Houston) was obtained by 
screening CHO eDNA library with human 13-tubulin eDNA. 
Details for the cDNA isolation will be published elsewhere. 
CHO 13-tubulin cDNA probe was used in the hybridization 
experiments to estimate the levels of amplified pDR2-4 DNA 
sequences in these cells in reference to the 13-tubulin gene, 
which is not amplified in these cells (15). 
Fig. 4 c shows a Southern blot hybridization of CHO, VCR 
1.5, VCR 5, and VCR 15 with ~-tubulin eDNA. The hybrid- 
ization signals for these DNA samples were similar. We used 
densitometric methods to quantitatively analyze the hybrid- 
ization signal corresponding to the 2.6-kb fragment (Fig. 4 
c),  and  the  results  showed that  the  variations  fall within 
+4 % of those of the CHO DNA. This indicated that similar 
amounts  of DNA  were loaded onto each lane.  When the 
duplicate filter was used for hybridization with probe pDR2- 
4, the hybridization signals in the VCR DNA samples, but 
not the CHO sample, can be readily detected. After a pro- 
longed exposure time, however, we can see the hybridization 
signal in the CHO sample, indicating amplification of  pDR2- 
4 DNA sequences in the VCR cell lines. We used densitomet- 
ric methods to analyze the levels of DNA amplification in 
these MDR cells. About 40-, 45-, and 40-fold amplifications 
exist in the VCR 1.5, VCR 5, and VCR 15 cell, respectively 
(Table I). We note that the increase of DNA amplification be- 
tween VCR 1.5 and VCR 15 cells is very small, if any. How- 
Figure 4.  Southern blot hybridization analysis of genomic DNAs 
from wild-type CHO and VCR mutants. (a) Hybridization pattern 
when the cosmid pDR6 was used as a probe to hybridize with 10 
I~g of EcoRI-digested CHO-, VCR  1.5-, VCR 5-, and VCR  15- 
blotted DNAs (lanes 1-4, respectively). (Lanes 1-4) 24-h exposure, 
lane 5 is a 48-tl exposure of the VCR 15 lane. (b and c) Hybridiza- 
tion analyses of pDR2-4 and CHO I~-tubulin eDNA, respectively, 
hybridized  to duplicate  blots  containing  10  pg  EcoRI-digested 
CHO, VCR  1.5, VCR 5, and VCR  15 DNAs (lanes 1-4, respec- 
tively). Exposure times were 3 h (b) and 24 h (c). Lane b5 shows 
extended exposure (24 h) of the CHO lane (lane bl). 
ever, the level of resistance to vincristine increase 12.5-fold 
between these two cell lines. 
We note that two hybridization bands  corresponding to 
4.6-  and  4-kb  EcoRI  fragments  were  detected  with  the 
pDR2-4 probe. This suggests that two DNA sequences ho- 
mologous to the insert of pDR2-4 were coamplified in these 
VCR mutants. It is obvious however that the sequence con- 
taining the 4-kb EcoRI fragment is amplified several folds 
more than the one with the 4.6-kb fragment. 
In an attempt to analyze whether any messenger RNA was 
transcribed from the amplified DNA  sequences,  we used 
pDR2-4 as a probe in Northern blot hybridization analysis 
of 5  pg blotted poly (A)  + RNAs from wild-type and VCR 
1.5 cells. A hybridization signal corresponding to a 4.3-kb 
mRNA can be clearly observed in the samples derived from 
VCR  mutants,  but only barely detectable in  the  sensitive 
CHO sample (Fig. 5, lane 1 ). Prolonged exposure of the au- 
toradiographic film clearly showed that the 4.3-kb mRNA 
were also expressed in the sensitive CHO cells (Fig. 5, lane 
9). The hybridized probe was denatured by boiling it in dis- 
tilled H20 for 5 rain. The poly (A)  ÷ RNA on the same filter 
was  rehybridized with  32p-labeled  CHO  IEi-tubulin eDNA 
probe.  Similar  intensities  of hybridization  signals  corre- 
sponding to  1.8-kb  and  2.6-kb 13-tubulin mRNA  were de- 
tected (Fig. 5 lanes 3 and 4), suggesting that similar amounts 
of poly (A)  + RNA was loaded in this experiment. Again, 
densitometric methods in combination with use of  autoradio- 
graphic films that were exposed for different lengths of time 
(for CHO sample) were used to estimate the level of mRNA 
production in VCR  1.5 cells. The abundance of the 4.3-kb 
mRNA is '~40 times higher in VCR 1.5 cells than that in the 
CHO cells, a level roughly consistent with that of DNA am- 
plification in this cell line. 
Fig. 5 also shows the results of a Northern blot of total cel- 
lular RNA isolated from CHO, VCR 1.5, VCR 5, and VCR 
15 (lanes 5-8) hybridized with pDR2-4 plus I~-tubulin eDNA 
probes.  We used total RNA  instead of poly (A)  + RNA  in 
this experiment to avoid the problem of differing levels of 
rRNA  contamination in  respective samples,  which  would 
make a quantitative estimate of the levels of overproduction 
of mRNA more difficult. We have found that rRNA contents 
in  different preparations of poly (A)  + RNA  samples  vary 
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*EDso 
Level of DNA  Level of 4.3-kb 
Cell line  Vincristine  Colcemid  Ethidium bromide  Puromycin  amplification  mRNA production 
CHO  0.05  (l)§  0.15  (1)  2.0 (1)  10 (1)  1  1 
VCR  1.5  2.0 (40)  2.0 (20)  30.0 (15)  400 (40)  40  40 
VCR  5.0  10.0 (200)  8.0 (80)  200.0  (100)  1000 (100)  45  40 
VCR 15.0  25.0 (500)  ND  ND  1500 (150)  40  40 
ND, not determined. 
* Dose of drug that kills 50% of cells. (EDso, I.tg/ml). 
§ Numbers indicated in parenthesis correspond  to level of resistance, when wild-type  CHO is normalized to 1. The levels of DNA amplification  and overexpres- 
sion of mRNA in the mutant cells are also expressed in relative values considering the basal level in the parental CHO cells as 1. These values were estimated 
from the densitometric scans of the corresponding  autoradiographs. 
(not  shown).  The  hybridization  signals  corresponding  to 
2.6-kb and  1.8-kb given by the I~-tubulin eDNA probe, was 
not significantly different in VCR RNA samples,  thus indi- 
cating that similar amounts of mRNA were loaded.  The hy- 
bridization  signals  corresponding  to  4.3  kb,  given by  the 
pDR2-4 probe,  were  not significantly different among the 
VCR  1.5,  VCR 5, and VCR  15 samples.  Our densitometric 
estimates showed that the levels of  4.3 kb in these VCR RNA 
samples varied by at most  +2%.  These results suggest that 
the levels of steady-state mRNA production are not different, 
and certainly not correlated to the levels of drug resistance 
in these  stepwise selected MDR mutants. 
pDR2-2 was similarly  used as a  probe for Northern hy- 
bridization.  The  results  demonstrate  that this  flanking  re- 
striction fragment does not hybridize with the 4.3-kb mRNA 
(data not shown). 
Localization of the Amplified DNA Sequences 
in the VCR Mutants 
We performed in situ hybridization to localize the amplified 
DNA sequences in the VCR lines to determine whether the 
amplified  DNA  sequences  are  localized  in  the  additional 
chromosomal region on the Z7 marker chromosome. Fig. 6, 
a  and b shows the results of using an entire pDR6 as a probe 
in  hybridization  of VCR  1.5  and  VCR  15  chromosomes, 
respectively.  In each case,  >25 metaphase plates were ana- 
lyzed,  the  silver grains  were  consistently  clustered  on the 
long arm of one of the two longest chromosomes. Even with- 
out using banding analysis, this chromosome can be readily 
identified as either chromosome 1 or Z1.  The chromosome 
that contains the amplified DNA sequences is markedly dif- 
ferent from the Z7  marker chromosome. 
Similar results were obtained when repeat-free DNA was 
used as a probe in in situ hybridization experiments.  Fig. 6, 
c and d  show the results of using insert pDR2-4 as a  probe 
in hybridizations to VCR 1.5 and VCR 15 cells, respectively. 
An analysis of >50 metaphase plates in each cell line shows 
that the distribution  of silver grains is concentrated on the 
region proximal to the telomere of chromosome lq or Zlq 
(Fig.  6, c, d,  and inserts). 
Discussion 
Gene amplification in drug-resistant animal cells selected by 
stepwise increases of drug concentrations has been reported 
in a  number of systems (for review,  see references 25, 29). 
We report here that amplification of a specific gene can also 
take place  in VCR CHO cells  that exhibit multidrug cross 
resistance. 
The characteristics of  gene amplification manifested in our 
VCR cell lines are as follows: 
(a) Neither the level of gene amplification nor the level of 
the 4.3-kb transcript in our VCR mutants  strictly correlate 
with the level of drug resistance. Our VCR 1.5 cells (40-fold 
drug  resistance)  contained  ,,o40-fold  amplification  of the 
gene. Further selection to ,'o500-fold resistance (VCR 15) did 
not result in additional amplification of the gene or increase 
in the accumulation of the 4.3-kb RNA transcript.  Our fail- 
ure to detect increased amplification of the DNA sequences 
in either VCR 5 or VCR  15 cells  suggests that either addi- 
tional genetic loci may be involved or a posttranscriptional 
regulation of the 4.3-kb mRNA is responsible for increased 
resistance  of vincristine. 
We have additional evidence showing that this observation 
is also applicable in another independently established MDR 
CHO cell line.  VBR 2,  an MDR CHO line established  by 
selection in vinblastine, is 10-fold less resistant to vincristine 
than  VCR  15  cells;  yet the level  of DNA amplification  in 
VBR 2.0 ceils is about the same as in VCR 15 cells (Sen, S., 
L.  D.  Teeter,  and T.  Kuo, manuscript  in preparation). 
Figure 5.  Northern blot hybridization analysis  of RNAs from the 
wild-type CHO and VCR mutants to pDR2-4 and/or CHO 13-tubulin 
eDNA. 5 ~tg poly (A)  ÷ lanes (1-4)  or 10 ~g total RNA (lanes 5-8) 
were separated by glyoxal gel electrophoresis and blotted onto Gene 
Screen membrane (New England Nuclear, Boston, MA). (Lanes I 
and 2) An autoradiogram of poly (A)  ÷ RNAs from CHO and VCR 
1.5, respectively,  hybridized with  pDR2--4.  (Lanes 3 and 4) The 
same blot hybridized with  I]-tubulin  eDNA.  In lanes  5-8,  total 
RNAs from CHO, VCR 1.5, VCR 5, and VCR 15, respectively, were 
hybridized with both pDR2-4 and 13-tubulin. Exposure times were 
3 and 6 h for lanes 1-4 and 5-8, respectively.  (Lane 9) A 65-h ex- 
posure time of the CHO sample in lane 1, a low basal  level of the 
4.3-kb transcript is evident. 
Teeter et al. DNA Amplification in Multidrug-resistant CHO Cells  1163 Figure 6.  In situ hybridization localization of the amplified  DNA sequences in the VCR 1.5 cells (a and c) and VCR 15 cells (b and d) 
using the probes pDR6 (a and b), containing a 40-kb-long sequence,  and pDR2-4 (c and d) a repeat-free  sequence of "~4 kb derived from 
pDR6.  (a and b) Metaphase  spreads.  Note that only one of the two longest chromosomes contain the silver grains on its long arm. The 
lower part in the same panel shows cut-out chromosomes that contain clusters  of silver grains.  (c and d) Metaphase  spreads,  each with 
the grain clusters  localized on the long arm of one number 1 chromosomes. (Inset)  A composite distribution  of labeled sites on number 
1 chromosomes for >50 cells  analyzed, a  and b exposed  6 d; c and d,  12 d. 
(b) The amplified genes in the drug-resistant mutants that 
have been published in the literature  are usually located in 
abnormal chromosomal structures,  either DM or homoge- 
nous staining region. The amplified gene in our VCR mutant 
is  not  located  at  the  abnormal  additional  chromosomal 
regions on Z7.  An explanation why the amplified DNA in 
chromosome 1 (or Z1)  in our VCR cells show no homoge- 
nous staining region-like structure that was described in well 
known  methotrexate-resistant  CHO  cells  (4),  may  be  be- 
cause the level  of amplification is too low and/or the am- 
plification DNA domain is too small.  Fougere-Deschatrette 
et al.  (9) have shown that in methotrexate-resistant rat hepa- 
toma cell lines with 40-50-fold amplification of DNA seg- 
ments  hybridizing  to  dihydrofolate  reductase,  substantial 
The Journal of Cell Biology,  Volume 103, 1986  1164 variation in karyological manifestations were observed. In- 
terestingly, in one clone, no chromosomal modification was 
observed. 
The fact that only "~50% of VCR 1.5 cells contain DM in 
a clonally selected MDR mutant suggests that the DNA se- 
quences in DM may not be solely responsible for MDR. Our 
in situ hybridization data showed that the amplified DNA se- 
quences are located on the long aim of chromosome Z1 (or 
1) in this cell line. We do not know whether the same am- 
plified DNA sequences are also present in DM. Owing to the 
difficulty that  DM  were  unidentifiable under  autoradio- 
graphic film after metaphase plates were treated with HCI/ 
NaOH or heat for hybridization (not shown), in situ hybrid- 
ization failed to provide unambiguous evidence that the sil- 
ver grains were not distributed on the DM. Fractionation of 
DM from VCR 1.5 ceils chromosomes to implicate their in- 
volvement in amplification is technically difficult, due to the 
problem of chromosome fragmentations that may be copuri- 
fled with DM. 
Despite a number of studies, the mechanisms of MDR in 
animal cells have not been elucidated. In this report,  we 
show that the DNA sequences amplified in the cell lines used 
by Roninson et al. (24) are also amplified in our VCR cell 
lines. We also have preliminary evidence that the same DNA 
sequences are amplified in other MDR CHO mutants in- 
dependently selected for resistance to vinblastine and adri- 
amyein (Sen, S., L. D. Teeter,  and T. Kuo, manuscript in 
preparation).  Amplifcation of similar genes has recently 
been detected in other independently established cell lines 
(26, 28, 33).  These results, together with those reported by 
Roninson et al. (24), indicate that the same DNA sequences 
are commonly amplified in several MDR CHO cells. Addi- 
tionally, several lines of evidence suggest that this gene may 
be related to the P-glycoprotein gene reported by Ling and 
his associates (23).  (a) The P-glycoprotein gene is also am- 
plified in a number of cell lines exhibiting the MDR pheno- 
type (23, 33), including the VCR 5 cell line described here 
(23).  (b) The P-glycoprotein gene also encodes a transcript 
of about the same size. (c) The P-glycoprotein gene has been 
in situ localized to Chinese hamster chromosome lq  3-8 
(30). (d) The restriction fragments that are hybridized with 
the P-glycoprotein gene probe are very similar to those in 
Fig. 4 a. (e) Both Ling's probe and the pDR2-4 probe de- 
scribed  here  are  highly conserved,  i.e.,  both  are  cross- 
hybridizable to human DNA under relative stringent hybrid- 
ization conditions (23, and our unpublished observations). 
Whether the P-glycoprotein gene is responsible for MDR 
in  animal  cells  requires  further  investigation  by  DNA- 
mediated gene transfer of a full length eDNA inserted into 
an expressible vector.  However,  we have another type of 
functional evidence linking chromosomes 1 and Z1  in our 
VCR ceils with the maintenance of the PDR phenotype. In 
somatic cell hybrids prepared from a fusion of VCR CHO 
and sensitive mouse cells, the loss of CHO chromosomes 1 
and Z1 is concomittant with loss of resistance in segregants 
(Teeter, L. D., J. A. Sanford, S. Sen, R. L. Stallings, M. J. 
Siciliano, and M. T. Kuo, manuscript submitted for publi- 
cation). 
An important aspect of drug resistance in cancer chemo- 
therapy is knowing how often MDR occurs in clinical sam- 
pies. Ling and his associates (3) have detected overproduc- 
tion  of the  P-glycoprotein  in  some  human  solid  tumor 
biopsies using a  monoclonal antibody. With the available 
cloned amplified DNA described here, it will be of signifi- 
cance to test whether gene amplification and overexpression 
of amplified gene have occurred in tumor cells, especially 
those derived from patients for whom chemotherapy has 
failed. We are currently using the insert of  pDR2-4 as a probe 
to isolate the homologous human gene for this purpose. 
We are indebted to Dr. I. Roninson for sending us his pDRI.1 clone; to Drs. 
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